A Double Blind Randomised Control Trial on Neuroprotection of Amiloride in Optic Neuritis
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Amiloride (Primary)
- Indications Multiple sclerosis; Optic neuritis
- Focus Pharmacodynamics
- Acronyms ACTION
- 17 May 2018 Biomarkers information updated
- 08 Dec 2013 Accrual to date is 21% according to United Kingdom Clinical Research Network.
- 18 Sep 2013 Accrual to date is 6% according to United Kingdom Clinical Research Network.